Tarbox Family Office’s Meridian Bioscience Inc VIVO Stock Holding History

Tarbox Family Office’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-128	Closed	-$3K	–	1073
2022 Q1	$3K	Hold	128	–	–	﹤0.01%	755
2021 Q4	$3K	Hold	128	–	–	﹤0.01%	826
2021 Q3	$2K	Hold	128	–	–	﹤0.01%	993
2021 Q2	$3K	Hold	128	–	–	﹤0.01%	877
2021 Q1	$3K	Hold	128	–	–	﹤0.01%	824
2020 Q4	$2K	Hold	128	–	–	﹤0.01%	930
2020 Q3	$2K	Hold	128	–	–	﹤0.01%	877
2020 Q2	$3K	Hold	128	–	–	﹤0.01%	685
2020 Q1	$1K	Buy	128 +2	+2%	+$17	﹤0.01%	1055
2019 Q4	$1K	Buy	+126	New	+$1.18K	﹤0.01%	1094

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

Tarbox Family Office's VIVO Position: Q2 2022 in Review

Tarbox Family Office sold out of Meridian Bioscience Inc (VIVO) in Q2 2022, closing a stake of 128 shares — an estimated $3K sold.

Tarbox Family Office first reported a position in VIVO in Q4 2019 and held it in 10 quarters. The position peaked at $3K in Q1 2022. 216 funds tracked by Wall St. Rank hold VIVO as of Q2 2022.

Tarbox Family Office reported no remaining Meridian Bioscience Inc position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 128 Meridian Bioscience Inc shares in Q2 2022, an estimated $3K.
Tarbox Family Office first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 10 quarters.
Tarbox Family Office's Meridian Bioscience Inc position peaked at $3K in Q1 2022.
216 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.